The activated conformation of integrin β7 is a novel multiple myeloma–specific target for CAR T cell therapy

Naoki Hosen(The University of Osaka), Yukiko Matsunaga(Protein Research Foundation), Kana Hasegawa(The University of Osaka), Hiroshi Matsuno(The University of Osaka), Yuki Nakamura(The University of Osaka), Mio Makita(The University of Osaka), Kouki Watanabe(The University of Osaka), Mikako Yoshida(The University of Osaka), Kei Satoh(The University of Osaka), Soyoko Morimoto(The University of Osaka), Fumihiro Fujiki(The University of Osaka), Hiroko Nakajima(The University of Osaka), Jun Nakata(The University of Osaka), Sumiyuki Nishida(The University of Osaka), Akihiro Tsuboi(The University of Osaka), Yoshitaka Oka(The University of Osaka), Masahiro Manabe, Hiroyoshi Ichihara(Fuchu Hospital), Yasutaka Aoyama(Fuchu Hospital), Atsuko Mugitani(Fuchu Hospital), Takafumi Nakao(Osaka City General Hospital), Masayuki Hino(Osaka City University), Ryosuke Uchibori(Jichi Medical University), Keiya Ozawa(Jichi Medical University), Yoshihiro Baba(Kyushu University), Seitaro Terakura(Nagoya University), Naoki Wada(The University of Osaka), Eiichi Morii(The University of Osaka), Junichi Nishimura(The University of Osaka), Kiyoshi Takeda(Japan Agency for Medical Research and Development), Yusuke Oji(The University of Osaka), Haruo Sugiyama(The University of Osaka), Junichi Takagi(Protein Research Foundation), Atsushi Kumanogoh(Japan Agency for Medical Research and Development)
Nature Medicine
November 6, 2017
Cited by 142

Abstract


Related Papers

No related papers found

Powered by citation graph analysis